THE EFFECT OF FUT-175 (NAFAMSTAT MESILATE) ON C-3A, C-4A AND C-5A GENERATION INVITRO AND INFLAMMATORY REACTIONS INVIVO

被引:37
作者
ISSEKUTZ, AC
ROLAND, DM
PATRICK, RA
机构
[1] DALHOUSIE UNIV, DEPT PEDIAT & MICROBIOL, HALIFAX B3H 4H2, NS, CANADA
[2] CIBA GEIGY CORP, SUMMIT, NJ 07901 USA
来源
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1990年 / 12卷 / 01期
基金
英国医学研究理事会;
关键词
D O I
10.1016/0192-0561(90)90062-R
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
FUT-175 is a synthetic protease inhibitor and an inhibitor of the classical and alternate pathways of complement activation. In human serum, FUT-175 inhibited C3a, C4a and C5a generation induced by heat aggregated IgG, zymosan and Cobra venom factor with IC50 values in the range of 3-43 μM depending on the stimulus and the fragments. To assess in vivo anti-inflammatory activity, inflammatory reactions induced in the skin of rabbits were quantitated by using 125I-albumin extravasation, 51Cr-labelled leukocyte accumulation and 86RbCl accumulation as a measure of hyperemia. Infusion of FUT-175 at 2 mg/kg/h inhibited all three parameters by 50-80% in dermal reactions induced by killed E. coli, zymosan, immune complexes, the reversed Arthus reaction, zymosan activated plasma (ZAP), f-norleu-leu-phe (FNLP) and LTB4. In contrast, the response to endotoxin (0.1 μg) was not effected by FUT-175 treatment. The effect of FUT-175 was comparable to that of local or systemic therapy with indomethacin, but unlike indomethacin, the effect of FUT-175 was not reversed by local PGE2 administration. Furthermore, indomethacin and FUT-175 had additive anti-inflammatory effects. These results suggest that although FUT-175 is a potent inhibitor of C3a, C4a and C5a generation, it has novel and broad anti-inflammatory effects, possibly through actions in addition to complement inhibition as indicated by inhibition of FNLP-, LTB4- and ZAP-induced reactions. © 1989.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 29 条
[1]   PHARMACOLOGICAL STUDIES OF FUT-175, NAFAMSTAT MESILATE .1. INHIBITION OF PROTEASE ACTIVITY IN INVITRO AND INVIVO EXPERIMENTS [J].
AOYAMA, T ;
INO, Y ;
OZEKI, M ;
ODA, M ;
SATO, T ;
KOSHIYAMA, Y ;
SUZUKI, S ;
FUJITA, M .
JAPANESE JOURNAL OF PHARMACOLOGY, 1984, 35 (03) :203-227
[2]  
AOYAMA T, 1984, Drugs of the Future, V9, P747
[3]   INTERLEUKIN-1 ACTS ON CULTURED HUMAN VASCULAR ENDOTHELIUM TO INCREASE THE ADHESION OF POLYMORPHONUCLEAR LEUKOCYTES, MONOCYTES, AND RELATED LEUKOCYTE CELL-LINES [J].
BEVILACQUA, MP ;
POBER, JS ;
WHEELER, ME ;
COTRAN, RS ;
GIMBRONE, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (05) :2003-2011
[4]  
COCHRANE CG, 1970, J IMMUNOL, V105, P55
[5]  
COCHRANE CG, 1974, INFLAMMATORY PROCESS, P85
[6]   ACUTE-INFLAMMATION INDUCED BY IMMUNE-COMPLEXES IN THE MICROCIRCULATION [J].
CRAWFORD, JP ;
MOVAT, HZ ;
MINTA, JO ;
OPAS, M .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1985, 42 (02) :175-193
[7]  
FERNANDEZ HN, 1978, J IMMUNOL, V120, P109
[8]   NEW SYNTHETIC INHIBITORS OF CIRBAR, CI ESTERASE, THROMBIN, PLASMIN, KALLIKREIN AND TRYPSIN [J].
FUJII, S ;
HITOMI, Y .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 661 (02) :342-345
[9]   STIMULATION OF THE ADHERENCE OF NEUTROPHILS TO UMBILICAL VEIN ENDOTHELIUM BY HUMAN RECOMBINANT TUMOR-NECROSIS-FACTOR [J].
GAMBLE, JR ;
HARLAN, JM ;
KLEBANOFF, SJ ;
VADAS, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (24) :8667-8671
[10]   TISSUE-INJURY IN INFLAMMATION - OXIDANTS, PROTEINASES, AND CATIONIC PROTEINS [J].
HENSON, PM ;
JOHNSTON, RB .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (03) :669-674